Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 189

The DOI matches its Crossref record.

Prostate Cancer Early Detection

Open access
Kawachi, Mark H., Bahnson, Robert R., Barry, Michael, Busby, J. Erik, Carroll, Peter R., Carter, H. Ballentine, Catalona, William J., Cookson, Michael S., Epstein, Jonathan I., Etzioni, Ruth B., Giri, Veda N., Hemstreet, George P., Howe, Richard J., Lange, Paul H., Lilja, Hans, Loughlin, Kevin R., Mohler, James, Moul, Judd, Nadler, Robert B., Patterson, Stephen G., Presti, Joseph C., Stroup, Antoinette M., Wake, Robert, Wei, John T. · 2010 · Journal of the National Comprehensive Cancer Network

Abstract

Because guidelines for the early detection of prostate cancer were developed by the ACS in the early 1990s, many variants of the total PSA assay have been introduced in attempts to increase the sensitivity of screening programs (cancer detection) while maintaining their specificity (elimination of unnecessary biopsies). Again, it is important to note that the NCCN guidelines recommend a method by which individuals and their physicians can use these new methods rationally for the early detection of prostate cancer. These guidelines are not designed to provide an argument for the use of early detection programs for prostate cancer. Rather, they are meant to provide a vehicle by which early detection efforts can be practiced in an evidence-based, systematic fashion in patients who choose to participate in such programs. The NCCN guidelines incorporate many new validated findings in addition to the DRE and PSA test. These new factors include percent-free PSA, PSA velocity, PSA testing intervals, biopsy pathology, and TRUS-guided biopsy techniques. The panel will re-examine the clinical utility of these new modalities annually and the guidelines will be modified accordingly. In addition, future iterations of these guidelines may incorporate new serum markers currently undergoing clinical investigation. It is the hope of the NCCN and this guideline panel that these algorithms will achieve the goal of assisting patients and clinicians who are choosing a program of early detection for prostate cancer to make decisions regarding the need for prostate biopsy. Any clinician who uses these guidelines is expected to exercise independent medical judgment in the context of the individual clinical circumstances to determine the patient's need for prostate biopsy. These guidelines will continue to evolve as the field of prostate cancer advances.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2010.0016

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 189

Metadata

Authors
Kawachi, M. H., Bahnson, R. R., Barry, M., Busby, J. E., Carroll, P. R., Carter, H. B., Catalona, W. J., Cookson, M. S., Epstein, J. I., Etzioni, R. B., Giri, V. N., Hemstreet, G. P., Howe, R. J., Lange, P. H., Lilja, H., Loughlin, K. R., Mohler, J., Moul, J., Nadler, R. B., Patterson, S. G., Presti, J. C., Stroup, A. M., Wake, R., & Wei, J. T.
Venue
Journal of the National Comprehensive Cancer Network
Published
2010-02
Volume
8
Issue
2
Pages
240-262
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
OpenAlex
W2307889165
Cited by
189
References
0
FWCI
15.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prostate Cancer Early Detection. https://app.cochat.ai/papers/10.6004/jnccn.2010.0016
The paper
Kawachi, M. H., Bahnson, R. R., Barry, M., Busby, J. E., Carroll, P. R., Carter, H. B., Catalona, W. J., Cookson, M. S., Epstein, J. I., Etzioni, R. B., Giri, V. N., Hemstreet, G. P., Howe, R. J., Lange, P. H., Lilja, H., Loughlin, K. R., Mohler, J., Moul, J., Nadler, R. B., . . . Wei, J. T. (2010). Prostate Cancer Early Detection. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2010.0016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.